4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001549595-25-000100
Chief Legal Officer sold 3,841 shares at $12.01 ($46,134)
- Chief Legal Officer acquired 10,532 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ring Christine · Chief Legal Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-07-30 | Exercise or conversion : show line 1 in the form | +1,924 | 39,242 | D | ||
| 2025-07-30 | Exercise or conversion : show line 2 in the form | +2,000 | 41,242 | D | ||
| 2025-07-30 | Exercise or conversion : show line 3 in the form | +3,750 | 44,992 | D | ||
| 2025-07-30 | Exercise or conversion : show line 4 in the form | +2,858 | 47,850 | D | ||
| 2025-07-30 | Sale : show line 5 in the form | −3,841 | $12.01 | $46,134 | 44,009 | D |
| Open-market sales · 3,841 sh · avg $12.01 · $46,134 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-30 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −1,924 | 3,849 | D |
| 2025-07-30 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −2,000 | 6,000 | D |
| 2025-07-30 | Exercise or conversion : show line 8 in the form Restricted Stock Units | −3,750 | 26,250 | D |
| 2025-07-30 | Exercise or conversion : show line 9 in the form Restricted Stock Units | −2,858 | 31,442 | D |
Loading xslF345X05/wk-form4_1753915738.xml…